Commercial drug | Product Name | Isotype |
Farletuziumab | Anti-Human FOLR1 Monoclonal Antibody(Farbio) | Human IgG1(E356D/M358L)-Kappa |
Fasinumab | Anti-Human NGF Monoclonal Antibody(Fasbio) | Human IgG4(S228P)-Kappa |
Fezakinumab | Anti-Human IL-22 Monoclonal Antibody(Fezbio) | Human IgG1(KDel)- Lambda 2(K83R) |
Ficlatuzumab | Anti-Human HGF Monoclonal Antibody(Ficbio) | Human IgG1(K214R)-Kappa |
Figitumumab | Anti-Human IGF1R Monoclonal Antibody(Figbio) | Human IgG2(KDel)-Kappa |
Fletikumab | Anti-Human IL-20 Monoclonal Antibody(Flebio) | Human IgG4(S228P)-Kappa |
Foralumab | Anti-Human CD3E Monoclonal Antibody(Forbio) | Human IgG1-Kappa |
Fremanezumab | Anti-Human CGRP Monoclonal Antibody(Frembio) | Human IgG2(A326S/P327S)-Kappa |
Fresolimumab | Anti-Human TGFB Monoclonal Antibody(Frebio) | Human IgG4(S228P)-Kappa |
Fresolimumab | Anti-Human TGFB Monoclonal Antibody(Frebio) | Human IgG4-Kappa |
Fulranumab | Anti-Human NGF Monoclonal Antibody(Fulbio) | Human IgG2-Kappa |
Galcanezumab | Anti-Human CGRP Monoclonal Antibody(Galbio) | Human IgG4(S228P/F234A/L235A/KDel)-Kappa |
Gantenerumab | Anti-Human amyloid β Monoclonal Antibody(Ganbio) | Human IgG1(E356D/M358L)-Kappa |
Gemtuzumab | Anti-Human SIGLEC3 Monoclonal Antibody(Gembio) | Human IgG4 (S228P)-Kappa |
Gevokizumab | Anti-Human IL-1B Monoclonal Antibody(Gevbio) | Human IgG1(K214R)-Kappa |
Girentuximab | Anti-Human CA9 Monoclonal Antibody(Girbio) | Human IgG1(E356D/M358L)-Kappa |
Glembatumumab | Anti-Human GPNMB Monoclonal Antibody(Glebio) | Human IgG2-Kappa |
Guselkumab | Anti-Human IL-23 Monoclonal Antibody(Gusbio) | Human IgG1(E356D/M358L)--Lambda2 |
Ibalizumab | Anti-Human CD4 Monoclonal Antibody(Ibabio) | Human IgG4-Kappa |
Ieramilimab | Anti-Human LAG3 Monoclonal Antibody(Lerbio) | Human IgG4(S228P/KDel)-Kappa |
Ifinatamab | Anti-Human B7-H3 Monoclonal Antibody(Ifibio) | Human IgG1(K214R)-kappa |
Indusatumab | Anti-Human GUCY2C Monoclonal Antibody(Indbio) | Human IgG1(E356D/M358L)-Kappa |
Iratumumab | Anti-Human CD30 Monoclonal Antibody(Irabio) | Human IgG1(E356D/M358L/436YDel)-Kappa |
Isatuximab | Anti-Human CD38 Monoclonal Antibody(Isabio) | Human IgG1(E356D/M358L)-Kappa |
Ivuxolimab | Anti-Human OX40 Monoclonal Antibody(Ivubio) | Human IgG2-Kappa |
Ixekizumab | Anti-Human IL-17A Monoclonal Antibody(Ixebio) | Human IgG4(S228P)-Kappa |
labetuzumab | Anti-Human CEA Monoclonal Antibody(Labbio) | Human IgG1(K214R)-Kappa |
Lebrikizumab | Anti-Human IL-13 Monoclonal Antibody(Lebbio) | Human IgG4(S228P)-Kappa |
Lemzoparlimab | Anti-Human CD47 Monoclonal Antibody(Lembio) | Human IgG4 (S228P)-Kappa |
Lenzilumab | Anti-Human CSF2 Monoclonal Antibody(Lenbio) | Human IgG1(K214R)-Kappa |
Lirilumab | Anti-Human CD158A Monoclonal Antibody(Lirbio) | Human IgG4(S228P)-Kappa |
Lucatumumab | Anti-Human CD40 Monoclonal Antibody(Lucbio) | Human IgG1(S131A/K214R)-Kappa |
Lusvertikimab | Anti-Human IL-7RA Monoclonal Antibody(Lusbio) | Huamn IgG4(S228P/L445P)-Kappa |
Magrolimab | Anti-Human CD47 Monoclonal Antibody(Magbio) | Human IgG4(S228P)-Kappa |
Margetuximab | Anti-Human HER2 Monoclonal Antibody(Marbio) | Human IgG1(K214R/L235V/E356D/M358L/F243L/R292P/Y300L/P396L)-Kappa |
Mavrilimumab | Anti-Human CSF2RA Monoclonal Antibody(Mavbio) | Human IgG4-Lambda2 |
Mirvetuximab | Anti-Human FOLR1 Monoclonal Antibody(Mirbio) | Human IgG1(E356D/M358L/KDel)-Kappa |
Monalizumab | Anti-Human CD159a Monoclonal Antibody(Monbio) | Human IgG4(S228P)-Kappa |
Motavizumab | Anti-Human RSV Monoclonal Antibody(Motbio) | Human IgG1(K214R)-Kappa |
Mupadolimab | Anti-Human CD73 Monoclonal Antibody(Mupbio) | Human IgG1(N297Q/E356D/M358L)-Kappa |
Muromonab | Anti-Human CD3E Monoclonal Antibody(OKT-3) | Mouse IgG2a(D134G)CH1+Human IgG1 CH2+CH3-Mouse Kappa |
Nadunolimab | Anti-Human IL1RAP Monoclonal Antibody(Nadbio) | Human IgG1(KDel)-Kappa |
Naxitamab | Anti-Human Ganglioside GD2 Monoclonal Antibody(Naxbio) | Human IgG1(K214R/E356D/M358L)-Kappa |
Necitumumab | Anti-Human EGFR Monoclonal Antibody(Necbio) | Human IgG1(F126L/K214R)-Kappa |
Nemolizumab | Anti-Human IL-31RA Monoclonal Antibody(Nembio) | Human
IgG2(C130S/R132K/E136G/S137G/C218S/H263Q/R350Q /Q414E/G441DEL/K442DEL)-Kappa |
Nesvacumab | Anti-Human Ang-2 Monoclonal Antibody(Nesbio) | Human IgG1(E356D/M358L)-Kappa |
Nipocalimab | Anti-Human FcRn Monoclonal Antibody(Nipbio) | Human IgG1(N297A/KDel)-Kappa |